Stockreport

I-Mab Biopharma GAAP EPS of -$0.48 [Seeking Alpha]

NovaBridge Biosciences - American Depositary Shares  (NBP) 
PDF The Company's current cash position is expected to support operations through 2028. Newsletters for Every Investor Get daily, sector-specific newsletters packed with [Read more]